Darrick Sealey
Psychiatric/Mental Health · Warner Robins, GANPI 1750053401
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 747 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,094, 7.1 times the $721 reported in 2021. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 747 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$1K
- AbbVie$1K
- plus $7K from 19 others
What the payments were for
- Food & beverage$16,624100%
- Education$590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 98 | $2,101 |
| Otsuka America Pharmaceutical, Inc. | 73 | $2,013 |
| Neurocrine Biosciences, Inc. | 60 | $1,856 |
| Teva Pharmaceuticals USA, Inc. | 73 | $1,664 |
| Alkermes, Inc. | 47 | $1,327 |
| AbbVie | 58 | $1,197 |
| Lundbeck LLC | 50 | $1,051 |
| Takeda Pharmaceuticals U.S.A., Inc. | 53 | $829 |
| Ironshore Pharmaceuticals Inc. | 36 | $618 |
| Corium, LLC | 27 | $610 |
| Vanda Pharmaceuticals Inc. | 25 | $590 |
| Johnson & Johnson | 21 | $422 |
| Supernus Pharmaceuticals, Inc. | 29 | $418 |
| E.r. Squibb & Sons, L.L.C. | 12 | $398 |
| Tris Pharma Inc | 24 | $340 |
| Axsome Therapeutics, Inc. | 7 | $221 |
| Neos Therapeutics, LP | 10 | $201 |
| Idorsia Pharmaceuticals US Inc | 9 | $176 |
| Collegium Pharmaceutical, Inc. | 9 | $165 |
| Noven Therapeutics, LLC | 8 | $146 |
| Sunovion Pharmaceuticals Inc. | 6 | $130 |
| Bausch Health US, LLC | 5 | $94 |
| Avanir Pharmaceuticals, Inc. | 5 | $82 |
| Brainsway USA Inc | 1 | $17 |
| Eisai Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,475
- CAPLYTA$729
- ARISTADA$520
- INGREZZA$502
- REXULTI$374
- ABILIFY MAINTENA$346
- COBENFY$250
- Austedo XR$249
- UZEDY$249
- VRAYLAR$230
- Fanapt$228
- ARISTADA INITIO$130
- AUSTEDO$125
- Azstarys$125
- ABILIFY ASIMTUFII$116
- SPRAVATO$107
- Auvelity$101
How this compares
$16,684 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Warner Robins
- Heather VealWarner Robins$12K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Olufunke AdewunmiSmyrna$13K
- Bradley MosherSuwanee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.